Xiao-Tong Zhang (Xiaotong Zhang, Zhang Xiaotong, Dingding Zhang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Topics

Systemic Lupus Erythematosus

Tyrosine Kinase

Top Venues

Thoracic cancer

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Therapeutic advances in chronic disease

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Zhao, Yang Wu, Yuan Yue, Min-Jiang Chen, Yan Xu, Xiangning Liu, Xiaoyan Liu, Xiaoxing Gao, Hanping Wang, Xiao-Yan Si, Wei Zhong, Xiao-Tong Zhang, Li Zhang, Mengzhao Wang
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer. Thoracic cancer 14 (5) (2023)
Jing Zhao, Yang Wu, Yuan Yue, Min-Jiang Chen, Yan Xu, Xiangning Liu, Xiaoyan Liu, Xiaoxing Gao, Hanping Wang, Xiao-Yan Si, Wei Zhong, Xiao-Tong Zhang, Li Zhang, Mengzhao Wang
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer. Thoracic cancer 14 (5) (2023)
Kang Miao, Xiao-Tong Zhang, Hanping Wang, Xiao-Yan Si, Li Zhang
Savolitinib versus crizotinib for treating MET positive non-small cell lung cancer. Thoracic cancer (2023)
Jing Zhao, Yang Wu, Yuan Yue, Min-Jiang Chen, Yan Xu, Xiangning Liu, Xiaoyan Liu, Xiaoxing Gao, Hanping Wang, Xiao-Yan Si, Wei Zhong, Xiao-Tong Zhang, Li Zhang, Mengzhao Wang
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer. Thoracic cancer (2023)
Xiao-Yan Si, Xueqing Zheng, Xinlun Tian, Hanping Wang, Yan Xu, Jing Zhao, Min-Jiang Chen, Wei Zhong, Mengzhao Wang, Li Zhang, Xiao-Tong Zhang
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case-control study. Thoracic cancer (2023)
Xiaoxing Gao, Ruili Pan, Min-Jiang Chen, Jing Zhao, Wei Zhong, Hanping Wang, Xiao-Yan Si, Xiao-Tong Zhang, Li Zhang, Yan Xu, Mengzhao Wang
Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis. Thoracic cancer 13 (7) (2022)
Kang Miao, Shuangni Yu, Jun Ni, Xiao-Tong Zhang, Li Zhang
Second primary tumor after immune checkpoint inhibitor therapy: A case report. Thoracic cancer 13 (7) (2022)
Tao Liu, Zi-Jian Xiang, Xiao-Meng Hou, Jing-Jing Chai, Yan-Li Yang, Xiao-Tong Zhang
Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Therapeutic advances in chronic disease 12 (2021)
Jun Ni, Xiao-Tong Zhang, Hanping Wang, Xiao-Yan Si, Yan Xu, Jing Zhao, Min-Jiang Chen, Li Zhang, Mengzhao Wang
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period. Thoracic cancer 13 (4) (2021)
Peng Song, Dongliang Yang, Hanping Wang, Xiaoxia Cui, Xiao-Yan Si, Xiao-Tong Zhang, Li Zhang
Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients. Thoracic cancer 11 (6) (2020)
Peng Song, Xiao-Tong Zhang, Xiaoxia Cui, Li Zhang
Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients. Thoracic cancer 11 (9) (2020)
Xiao-Yan Si, Ruili Pan, Shaohua Ma, Lin Li, Li Liang, Ping Zhang, Yuping Chu, Hanping Wang, Mengzhao Wang, Xiao-Tong Zhang, Li Zhang
Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer. Thoracic cancer 12 (3) (2020)
Jun Ni, Wang Hanping, Xiao-Yan Si, Yan Xu, Wang Mengzhao, Xiao-Tong Zhang, Zhang Li
Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study. Thoracic cancer 11 (7) (2020)
Peng Song, Dongliang Yang, Hanping Wang, Xiaoxia Cui, Xiao-Yan Si, Xiao-Tong Zhang, Li Zhang
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients. Thoracic cancer 11 (6) (2020)
Thomas Muley, Xiao-Tong Zhang, Stefan Holdenrieder, Catharina M Korse, Xiu-Yi Zhi, Rafael Molina, Zhongjuan Liu, Gunther Hartmann, Michel M van den Heuvel, Kun Qian, Ramon Marrades, Christine Engel, Ying He, Birgit Wehnl, Farshid Dayyani, Felix Herth
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 42 (9) (2020)
Yanyan Wu, Jun Ni, Xiaoyan Chang, Xiao-Tong Zhang, Li Zhang
Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non-small-cell lung cancer and ERBB2 mutation. Thoracic cancer 11 (7) (2020)
Xiao-Yan Si, Hanping Wang, Xiao-Tong Zhang, Mengzhao Wang, Yan You, Li Zhang
Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum-pemetrexed: The first report of two cases. Thoracic cancer 11 (8) (2020)
Ziwei Liu, Tao Liu, Xiao-Tong Zhang, Xiao-Yan Si, Hanping Wang, Jingjia Zhang, Hui Huang, Xuefeng Sun, Jinglan Wang, Mengzhao Wang, Li Zhang
Opportunistic infections complicating immunotherapy for non-small cell lung cancer. Thoracic cancer 11 (6) (2020)